Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study

OBJECTIVES: To evaluate retention, efficacy, and safety of subcutaneous (SC) abatacept over 2 years in patients with moderate-to-severe RA in the Abatacept SubCutaneOus in Routine clinical practicE (ASCORE) study. METHODS: Patients with RA who initiated SC abatacept 125 mg once weekly were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Mariette, Xavier, Flipo, René-Marc, Caporali, Roberto, Buch, Maya H., Patel, Yusuf, Marsal, Sara, Sanmartí, Raimon, Nurmohamed, Michael T., Griffiths, Hedley, Peichl, Peter, Bannert, Bettina, Chartier, Melanie, Connolly, Sean E., Lozenski, Karissa, Rauch, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287226/
https://www.ncbi.nlm.nih.gov/pubmed/35536413
http://dx.doi.org/10.1007/s10067-022-06176-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287226/
https://www.ncbi.nlm.nih.gov/pubmed/35536413
http://dx.doi.org/10.1007/s10067-022-06176-1

Ejemplares similares